Superficial Dyspareunia Clinical Trial
Official title:
Trans-gluteal Versus Trans-vaginal Pudendal Nerve Fluoroscopic Guided Pulsed Radiofrequency for Treatment of Superficial Dyspareunia: a Prospective Cohort Study
NCT number | NCT04201041 |
Other study ID # | PNB |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 1, 2018 |
Est. completion date | March 25, 2020 |
Verified date | April 2020 |
Source | South Egypt Cancer Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Superficial dyspareunia represents a major health problem especially for the newly wed couples. Pulsed radiofrequency for pudendal nerve is a non-neurolytic neuromodulatory method that is effective in relief of this type of pain. Objectives: to evaluate the efficacy of bilateral pudendal nerve fluoroscopic guided pulsed radiofrequency in treatment of intractable non-organic dyspareunia, and compare between trans-gluteal and transvaginal approaches regarding patient comfort and satisfaction.
Status | Completed |
Enrollment | 40 |
Est. completion date | March 25, 2020 |
Est. primary completion date | March 20, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years to 46 Years |
Eligibility |
Inclusion Criteria: - women aged between 16 and 46 years and from a near vicinity to our facility to make her available for follow-up Exclusion Criteria: - We had excluded women with any abnormality in the transvaginal US guided imagining, or those with any evidence of local gynecological abnormalities on examination. Meanwhile, we had excluded those women with infection at site of injection, coagulopathy or other bleeding diathesis, pre-existing neurologic deficit in the targeted region, those with history of chronic opioid use and women who refused to participate in the study |
Country | Name | City | State |
---|---|---|---|
Egypt | South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt | Assiut |
Lead Sponsor | Collaborator |
---|---|
South Egypt Cancer Institute |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change in Numerical rating scale | 0 no pain and 10 maximum pain | baseline reading -1 day reading-3 days postoperative reading |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06142851 -
Management of Women With Superficial Dyspareunia
|